Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.
about
Long-Range RNA-RNA Interactions Circularize the Dengue Virus GenomeControl of Translation by the 5'- and 3'-Terminal Regions of the Dengue Virus GenomeA 5' RNA element promotes dengue virus RNA synthesis on a circular genomeInhibition of protein kinase C promotes dengue virus replicationInhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomersCastanospermine, a potent inhibitor of dengue virus infection in vitro and in vivoDengue and dengue hemorrhagic feverInhibition of interferon signaling by dengue virusGenetic dissection of Flaviviridae host factors through genome-scale CRISPR screensDengue Virus Genome Uncoating Requires UbiquitinationDevelopment and utility of an in vitro, fluorescence-based assay for the discovery of novel compounds against dengue 2 viral proteaseReplication in cells of hematopoietic origin is necessary for Dengue virus disseminationSubstitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entryNew mouse model for dengue virus vaccine testingAttenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccineEvolutionary relationships of endemic/epidemic and sylvatic dengue virusesDengue virus structural differences that correlate with pathogenesis.Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile VirusInhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of FlavivirusesEnvelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero CellsGenetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence.S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells.Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse ModelAmerican Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic CellsEssential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral PropagationType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesHigh Genetic Stability of Dengue Virus Propagated in MRC-5 Cells as Compared to the Virus Propagated in Vero CellsDengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine DevelopmentA Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral LoadsChanging the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis VirusDifferential Cholesterol Binding by Class II Fusion Proteins Determines Membrane Fusion PropertiesDetection and Serotyping of Dengue Virus in Serum Samples by Multiplex Reverse Transcriptase PCR-Ligase Detection Reaction AssayStructural and Functional Studies of the Promoter Element for Dengue Virus RNA ReplicationConformational Changes in the Solution Structure of the Dengue Virus 5' End in the Presence and Absence of the 3' Untranslated RegionThe capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesisDengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle FormationImmature Dengue Virus: A Veiled Pathogen?
P2860
Q22337048-2C0BDDE7-BB0E-4031-AEAC-AF21284BD1CBQ22337049-E4B495D7-A998-4DEA-BCD2-9A8CAB80EFEAQ22337098-19D8C735-7E9B-45FE-9BCF-D3D890A7BB5DQ24288866-3C0C916C-6B58-47D8-AA6F-94060D405BFBQ24520621-0BBFC4EF-FAC6-48D7-8319-B85867F8A075Q24531947-077CA7EA-B542-499A-91CF-BDE77AEA78CEQ24550739-89F7EAD0-669B-4874-B236-60F53C7C0C78Q24630622-116AFC8C-EB69-4689-9A36-245C85079986Q24705236-478DF8FD-CF0B-40C2-BD9E-8D6739AB131EQ25242049-A1856F4A-BD5D-4C6F-B029-F29E67B7EB73Q26700170-EA492FF3-3E89-417D-A791-405D8F678790Q27347892-899FD426-C5B3-4E02-8640-1DAD344C4DCFQ27469309-476FDE68-C5F2-4DB8-B5BD-21342B8865DFQ27469339-884CBF66-7F39-4B4A-B216-2292005176D5Q27469644-263BFEC8-482E-4CAE-BD52-131C4A5098F1Q27469646-2F12C8B3-5CE2-4B2A-AF6A-47D8A3EBBDBDQ27469648-7DB8DA16-BD7F-468C-AB67-61C4B6F5E8F5Q27469705-47565807-0143-4A3E-BF9E-B24F003B5754Q27469763-5476D63E-7465-431D-9A48-535ED347CFECQ27469831-4EBB138C-5EA9-4561-819A-EA3EE2FD5E5DQ27469841-41314D71-6460-43AC-AD58-79A11376CF34Q27469847-BD17543E-CE59-4B5E-A2B4-580B1A697F51Q27469935-653AFFF0-3874-4E6C-9912-742FECA4BB29Q27472563-44078FEA-6A1F-4F83-B7C2-3C91687B77DCQ27472677-6232E0C5-8BDE-4249-8CD4-C0EA887E361FQ27473317-984CE3A4-3765-45E2-B92A-A0762981707AQ27473379-CBA9513C-BCB4-4ADA-8466-BA16653AE37DQ27480927-A2749BFF-CB52-4187-A70E-52C424C246FEQ27485031-225F3E45-E7BA-4764-9AD8-567685D0BF5EQ27485473-EA7ECA3E-5A3C-45CB-87FB-13628A2A9701Q27485759-9C8CA95A-3B3A-41C4-9E4B-FD12A5F8D01FQ27486786-A0B283E6-F694-4949-AB00-2DB008E30646Q27486787-318AD48C-C9E1-46FA-A370-4F3C70E4B3BAQ27486916-1473FC9B-3169-4CA6-8EB6-FA19BC635385Q27487025-873E87A8-3691-454B-8B59-1D053E2906A3Q27487528-954C3786-E9FA-4CD4-827F-77B3E425A8B7Q27487533-3907903A-02D5-4AC9-89D3-2CB435C76821Q27487755-D494CD4A-F38D-4AC3-9528-AD35888AD284Q27489906-4E7FE744-9921-4293-A0B7-CFC43F0E54F7Q27490592-CF14C706-3BA7-4760-BC84-7C4825105302
P2860
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Construction of infectious cDN ...... ine derivative, strain PDK-53.
@en
type
label
Construction of infectious cDN ...... ine derivative, strain PDK-53.
@en
prefLabel
Construction of infectious cDN ...... ine derivative, strain PDK-53.
@en
P2093
P356
P1433
P1476
Construction of infectious cDN ...... ine derivative, strain PDK-53.
@en
P2093
Bhamarapravati N
Butrapet S
Roehrig JT
Tsuchiya KR
P304
P356
10.1006/VIRO.1997.8500
P407
P577
1997-04-01T00:00:00Z